In mAb NJ001‐treated SPC‐A1 cells, TIMP‐3 knockdown successfully reversed the inhibitory effect of mAb NJ001 on cancer cell invasiveness (Fig 3(d,e)). This evidence concerns the gene TIMP3 and cancer.